Fit-for-purpose biomarker method validation in anticancer drug developmentCUMMINGS, Jeffrey; WARD, Tim H; DIVE, Caroline et al.Drug discovery today. 2010, Vol 15, Num 19-20, pp 816-825, issn 1359-6446, 10 p.Article

Application of the β-expectation tolerance interval to method validation of the M30 and M65 ELISA cell death biomarker assaysCUMMINGS, Jeffrey; CONG ZHOU; DIVE, Caroline et al.Journal of chromatography. B. 2011, Vol 879, Num 13-14, pp 887-893, issn 1570-0232, 7 p.Article

Obesity and cancer : Pathophysiological and biological mechanismsRENEHAN, Andrew G; ROBERTS, Darren L; DIVE, Caroline et al.Archives of physiology and biochemistry. 2008, Vol 114, Num 1, pp 71-83, issn 1381-3455, 13 p.Conference Paper

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non―Small-Cell Lung CancerKREBS, Matthew G; SLOANE, Robert; RANSON, Malcolm et al.Journal of clinical oncology. 2011, Vol 29, Num 12, pp 1556-1563, issn 0732-183X, 8 p.Article

Serum biomarkers of apoptosisGREYSTOKE, Alastair; HUGHES, Andrew; RANSON, Malcolm et al.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 5, pp 115-127, issn 1359-6349, 13 p.Conference Paper

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursHORSLEY, Laura; CUMMINGS, Jeff; HALFORD, Sarah et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 6, pp 1343-1352, issn 0344-5704, 10 p.Article

Is Serum or Plasma More Appropriate for Intersubject Comparisons in Metabolomic Studies? An Assessment in Patients with Small-Cell Lung CancerWEDGE, David C; ALLWOOD, J. William; GOODACRE, Royston et al.Analytical chemistry (Washington). 2011, Vol 83, Num 17, pp 6689-6697, issn 0003-2700, 9 p.Article

Multiplexed Assays for Detection of Mutations in PIK3CABOARD, Ruth E; THELWELL, Nicola J; RAVETTO, Paul F et al.Clinical chemistry (Baltimore, Md.). 2008, Vol 54, Num 4, pp 757-760, issn 0009-9147, 4 p.Article

Circulating Biomarkers of Cell Death After Treatment with the BH-3 Mimetic ABT-737 in a Preclinical Model of Small-Cell Lung CancerMICHA, Dimitra; CUMMINGS, Jeff; SHOEMAKER, Alex et al.Clinical cancer research (Print). 2008, Vol 14, Num 22, pp 7304-7310, issn 1078-0432, 7 p.Article

Role of mitochondrial membrane permeabilization in apoptosis and cancerHENRY-MOWATT, Judith; DIVE, Caroline; MARTINOU, Jean-Claude et al.Oncogene (Basingstoke). 2004, Vol 23, Num 16, pp 2850-2860, issn 0950-9232, 11 p.Article

Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agentsHOLT, Sarah V; BROOKES, Karen E; DIVE, Caroline et al.Oncology reports. 2011, Vol 25, Num 4, pp 1177-1181, issn 1021-335X, 5 p.Article

The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian CancerBACKEN, Alison; RENEHAN, Andrew G; JAYSON, Gordon C et al.Clinical cancer research (Print). 2014, Vol 20, Num 17, pp 4549-4558, issn 1078-0432, 10 p.Article

Src Family Kinase Inhibitor Saracatinib (AZD0530) Impairs Oxaliplatin Uptake in Colorectal Cancer Cells and Blocks Organic Cation TransportersMORROW, Christopher J; GHATTAS, Mohammad; SMITH, Christopher et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 14, pp 5931-5941, issn 0008-5472, 11 p.Article

Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing ChemotherapyHOU, Jian-Mei; GREYSTOKE, Alastair; RANSON, Malcolm et al.The American journal of pathology. 2009, Vol 175, Num 2, pp 808-816, issn 0002-9440, 9 p.Article

The development of composite circulating biomarker models for use in anticancer drug clinical developmentLANCASHIRE, Lee J; ROBERTS, Darren L; DIVE, Caroline et al.International journal of cancer (Print). 2011, Vol 128, Num 8, pp 1843-1851, issn 0020-7136, 9 p.Article

Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cellsSTOVOLD, Rachel; BLACKHALL, Fiona; MEREDITH, Suzanne et al.Lung cancer. 2012, Vol 76, Num 3, pp 263-268, issn 0169-5002, 6 p.Article

Circulating biomarkers in hepatocellular carcinomaMORRIS, Karen L; TUGWOOD, Jonathan D; KATOH, Atsuhiko et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 2, pp 323-332, issn 0344-5704, 10 p.Article

Both stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenograftsMUSTAFI, Reba; DOUGHERTY, Urszula; FICHERA, Alessandro et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 10, pp 1930-1939, issn 0143-3334, 10 p.Article

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung CancerHOU, Jian-Mei; KREBS, Matthew G; WARD, Tim et al.Journal of clinical oncology. 2012, Vol 30, Num 5, pp 525-532, issn 0732-183X, 8 p.Article

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung CancerRUDIN, Charles M; HANN, Christine L; RANSON, Malcolm R et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3163-3169, issn 1078-0432, 7 p.Article

Liquid Chromatography―Mass Spectrometry Calibration Transfer and Metabolomics Data FusionVAUGHAN, Andrew A; DUNN, Warwick B; ALLWOOD, J. William et al.Analytical chemistry (Washington). 2012, Vol 84, Num 22, pp 9848-9857, issn 0003-2700, 10 p.Article

Circulating Tumor Cells as a Window on Metastasis Biology in Lung CancerHOU, Jian-Mei; KREBS, Matthew; WARD, Tim et al.The American journal of pathology. 2011, Vol 178, Num 3, pp 989-996, issn 0002-9440, 8 p.Article

Effect of prolonged formalin fixation on immunohistochemical staining for the proliferation marker Ki67HITCHMAN, Elizabeth; HODGKINSON, Cassandra; ROBERTS, Darren et al.Histopathology. 2011, Vol 59, Num 6, pp 1261-1263, issn 0309-0167, 3 p.Article

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancerBOARD, Ruth E; WARDLEY, Andrew M; DIVE, Caroline et al.Breast cancer research and treatment. 2010, Vol 120, Num 2, pp 461-467, issn 0167-6806, 7 p.Article

In silico screening and biological evaluation of inhibitors of Src-SH3 domain interaction with a proline-rich ligandATATREH, Noor; STOJKOSKI, Cvetan; SMITH, Phillippa et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 3, pp 1217-1222, issn 0960-894X, 6 p.Article